Literature DB >> 20440201

Nicotine and cocaine self-administration using a multiple schedule of intravenous drug and sucrose reinforcement in rats.

Dustin J Stairs1, Nichole M Neugebauer, Michael T Bardo.   

Abstract

There appears to be a relatively narrow range of contingencies in which intravenous (i.v) infusions of nicotine will maintain responding in rats. The schedule of reinforcement typically used when investigating i.v. nicotine self-administration is a simple fixed-ratio (FR) schedule. This study determined if responding in rats could be established using a multiple schedule of either i.v. cocaine or nicotine and sucrose reinforcement. Following training of individual components with each reinforcer, rats were placed on an FR15 60-s timeout multiple schedule of cocaine (0.3 mg/kg/infusion) and sucrose (45 mg pellets) reinforcement or an FR5 60-s timeout multiple schedule of nicotine (0.03 mg/kg/infusion) and sucrose (45 mg pellets) reinforcement. Both cocaine and nicotine maintained significant levels of responding under the multiple schedule. Pretreatment with the dopamine D1 antagonist SCH 23390 increased cocaine-maintained responding, but not sucrose responding. Acute pretreatment with the nicotinic antagonist mecamylamine or SCH 23390 specifically decreased nicotine self-administration. Extinction of the individual nicotine and sucrose components resulted in decreases in responding in each component under extinction. These results indicate that i.v. nicotine maintains responding under a multiple schedule. This procedure may be useful when studying the specificity of drug pretreatments on nicotine self-administration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20440201      PMCID: PMC3072058          DOI: 10.1097/FBP.0b013e32833a5c9e

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  35 in total

1.  Nicotine self-administration in rats.

Authors:  E C Donny; A R Caggiula; S Knopf; C Brown
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine.

Authors:  Mark G LeSage; Dan E Keyler; Don Shoeman; Donna Raphael; Gregory Collins; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2002-05       Impact factor: 3.533

3.  Nornicotine pretreatment decreases intravenous nicotine self-administration in rats.

Authors:  T A Green; S B Phillips; P A Crooks; L P Dwoskin; M T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2000-10       Impact factor: 4.530

4.  Reboxetine: attenuation of intravenous nicotine self-administration in rats.

Authors:  Anthony S Rauhut; Stephanie N Mullins; Linda P Dwoskin; Michael T Bardo
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

5.  Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat.

Authors:  S.B. Caine; G.F. Koob
Journal:  Behav Pharmacol       Date:  1995-06       Impact factor: 2.293

6.  Cocaine- and food-maintained responding under a multiple schedule in rhesus monkeys: environmental context and the effects of a dopamine antagonist.

Authors:  Michael A Nader; Rachna S Sinnott; Robert H Mach; Drake Morgan
Journal:  Psychopharmacology (Berl)       Date:  2002-08-29       Impact factor: 4.530

7.  Nicotine maintains robust self-administration in rats on a limited-access schedule.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency.

Authors:  E C Donny; A R Caggiula; M M Mielke; K S Jacobs; C Rose; A F Sved
Journal:  Psychopharmacology (Berl)       Date:  1998-03       Impact factor: 4.530

Review 9.  The scientific case that nicotine is addictive.

Authors:  I P Stolerman; M J Jarvis
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

10.  Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat.

Authors:  C B Hubner; J E Moreton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more
  9 in total

1.  Nicotine and ethanol co-use in Long-Evans rats: Stimulatory effects of perinatal exposure to a fat-rich diet.

Authors:  Olga Karatayev; Olga Lukatskaya; Sang-Ho Moon; Wei-Ran Guo; Dan Chen; Diane Algava; Susan Abedi; Sarah F Leibowitz
Journal:  Alcohol       Date:  2015-04-11       Impact factor: 2.405

Review 2.  Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction.

Authors:  Natalie A Hadad; Lori A Knackstedt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-06       Impact factor: 4.530

3.  Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse.

Authors:  A D Lê; Douglas Funk; Steven Lo; Kathleen Coen
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

4.  bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.

Authors:  Thomas E Wooters; Andrew M Smith; Marharyta Pivavarchyk; Kiran B Siripurapu; J Michael McIntosh; Zhenfa Zhang; Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 5.  Zebrafish for the study of the biological effects of nicotine.

Authors:  Eric W Klee; Jon O Ebbert; Henning Schneider; Richard D Hurt; Stephen C Ekker
Journal:  Nicotine Tob Res       Date:  2011-03-08       Impact factor: 4.244

6.  Differential stimulus control of drug-seeking: multimodal reinstatement.

Authors:  Seth R Batten; Joshua S Beckmann
Journal:  Addict Biol       Date:  2017-08-09       Impact factor: 4.280

7.  Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats.

Authors:  Megan M Kangiser; Linda P Dwoskin; Guangrong Zheng; Peter A Crooks; Dustin J Stairs
Journal:  Behav Pharmacol       Date:  2018-02       Impact factor: 2.293

Review 8.  Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.

Authors:  C E Van Skike; S E Maggio; A R Reynolds; E M Casey; M T Bardo; L P Dwoskin; M A Prendergast; K Nixon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-12       Impact factor: 5.067

Review 9.  The Winding Road to Relapse: Forging a New Understanding of Cue-Induced Reinstatement Models and Their Associated Neural Mechanisms.

Authors:  Mark D Namba; Seven E Tomek; M Foster Olive; Joshua S Beckmann; Cassandra D Gipson
Journal:  Front Behav Neurosci       Date:  2018-02-09       Impact factor: 3.558

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.